Skip to main content
NCBI home page
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
. 1993 Sep;75(5):339–344.

Factors influencing blood transfusion during adult liver transplantation.

M Deakin 1, B K Gunson 1, J A Dunn 1, P McMaster 1, G Tisone 1, J Warwick 1, J A Buckels 1
PMCID: PMC2497978  PMID: 8215151

Abstract

From 1982 to 1990, 300 adults received liver transplants in Birmingham UK with a median intraoperative blood transfusion rate of 23.5 units for the first 50 patients falling to 8 units for the last 50. The major factors in the reduction of blood usage were the experience of the team, the use of venovenous bypass and the use of an argon beam coagulator. Univariate analysis of preoperative factors in an attempt to predict patients at risk of excessive intraoperative transfusion showed that levels of serum sodium, urea, creatinine, haemoglobin, patient weight and the presence of ascites were significantly related to the quantity of blood transfused, although stepwise discriminant analysis showed that only blood urea and platelet count had an independent association with transfusion. The final model was poorly predictive of intraoperative transfusion requirements. Technical factors rather than patient-related factors are more important in the control of intraoperative bleeding in newly established transplant programmes.

Full text

PDF
339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bontempo F. A., Lewis J. H., Van Thiel D. H., Spero J. A., Ragni M. V., Butler P., Israel L., Starzl T. E. The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation. 1985 May;39(5):532–536. doi: 10.1097/00007890-198505000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Calne R. Y., Williams R., Rolles K. Liver transplantation in the adult. World J Surg. 1986 Jun;10(3):422–431. doi: 10.1007/BF01655302. [DOI] [PubMed] [Google Scholar]
  3. Cottam S., Hunt B., Segal H., Ginsburg R., Potter D. Aprotinin inhibits tissue plasminogen activator-mediated fibrinolysis during orthotopic liver transplantation. Transplant Proc. 1991 Jun;23(3):1933–1933. [PubMed] [Google Scholar]
  4. Dugdale M., Britt L. G., Vera S. R., Peters T. G., Williams J., Zimmermann A. G., Gaber A. O. Identification of the nature of hemostatic failure during transplantation of the liver. Transplant Proc. 1989 Feb;21(1 Pt 2):2332–2333. [PubMed] [Google Scholar]
  5. Dzik W. H., Arkin C. F., Jenkins R. L., Stump D. C. Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood. 1988 Apr;71(4):1090–1095. [PubMed] [Google Scholar]
  6. Foster J. H., Berman M. M. Solid liver tumors. Major Probl Clin Surg. 1977;22:1–342. [PubMed] [Google Scholar]
  7. Friend P. J., Lim S., Smith M., Jamieson N. V., Rolles K., O'Grady J., Williams R., Calne R. Y. Liver transplantation in the Cambridge/King's College Hospital series--the first 400 patients. Transplant Proc. 1989 Feb;21(1 Pt 2):2397–2398. [PubMed] [Google Scholar]
  8. Griffith B. P., Shaw B. W., Jr, Hardesty R. L., Iwatsuki S., Bahnson H. T., Starzl T. E. Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet. 1985 Mar;160(3):270–272. [PMC free article] [PubMed] [Google Scholar]
  9. Ickx B., Walker S., Farman J. V. Ionized calcium levels during liver transplantation. Eur J Anaesthesiol. 1987 Nov;4(6):421–427. [PubMed] [Google Scholar]
  10. Kang Y., De Wolf A. M., Aggarwal S., Campbell E., Martin L. K. In vitro study of the effects of aprotinin on coagulation during orthotopic liver transplantation. Transplant Proc. 1991 Jun;23(3):1934–1935. [PubMed] [Google Scholar]
  11. Kirby R. M., McMaster P., Clements D., Hubscher S. G., Angrisani L., Sealey M., Gunson B. K., Salt P. J., Buckels J. A., Adams D. H. Orthotopic liver transplantation: postoperative complications and their management. Br J Surg. 1987 Jan;74(1):3–11. doi: 10.1002/bjs.1800740103. [DOI] [PubMed] [Google Scholar]
  12. Lewis J. H., Bontempo F. A., Cornell F., Kiss J. E., Larson P., Ragni M. V., Rice E. O., Spero J. A., Starzl T. E. Blood use in liver transplantation. Transfusion. 1987 May-Jun;27(3):222–225. doi: 10.1046/j.1537-2995.1987.27387235624.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mallett S., Rolles K., Cox D., Burroughs A., Hunt B. Intraoperative use of aprotinin (Trasylol) in orthotopic liver transplantation. Transplant Proc. 1991 Jun;23(3):1931–1932. [PubMed] [Google Scholar]
  14. Marino I. R., Weber T., Esquivel C. O., Kang Y. G., Starzl T. E., Duquesnoy R. J. Intraoperative blood transfusion requirements and deficient hemostasis in highly alloimmunized patients undergoing liver transplantation. Transplant Proc. 1988 Dec;20(6):1087–1089. [PMC free article] [PubMed] [Google Scholar]
  15. Motschman T. L., Taswell H. F., Brecher M. E., Rettke S. R., Wiesner R. H., Krom R. A. Blood bank support of a liver transplantation program. Mayo Clin Proc. 1989 Jan;64(1):103–111. doi: 10.1016/s0025-6196(12)65309-9. [DOI] [PubMed] [Google Scholar]
  16. Nagao T., Inoue S., Goto S., Mizuta T., Omori Y., Kawano N., Morioka Y. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg. 1987 Jan;205(1):33–40. doi: 10.1097/00000658-198701000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Porte R. J., Bontempo F. A., Knot E. A., Lewis J. H., Kang Y. G., Starzl T. E. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation. 1989 Jun;47(6):978–984. doi: 10.1097/00007890-198906000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ritter D. M., Rettke S. R., Lunn R. J., Bowie E. J., Ilstrup D. Preoperative coagulation screen does not predict intraoperative blood product requirements in orthotopic liver transplantation. Transplant Proc. 1989 Jun;21(3):3533–3534. [PubMed] [Google Scholar]
  19. Rouch D. A., Thistlethwaite J. R., Lichtor L., Emond J. C., Broelsch C. E. Effect of massive transfusion during liver transplantation on rejection and infection. Transplant Proc. 1988 Dec;20(6):1135–1137. [PubMed] [Google Scholar]
  20. Royston D., Bidstrup B. P., Taylor K. M., Sapsford R. N. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet. 1987 Dec 5;2(8571):1289–1291. doi: 10.1016/s0140-6736(87)91190-1. [DOI] [PubMed] [Google Scholar]
  21. STARZL T. E., MARCHIORO T. L., VONKAULLA K. N., HERMANN G., BRITTAIN R. S., WADDELL W. R. HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. Surg Gynecol Obstet. 1963 Dec;117:659–676. [PMC free article] [PubMed] [Google Scholar]
  22. Shaw B. W., Jr, Martin D. J., Marquez J. M., Kang Y. G., Bugbee A. C., Jr, Iwatsuki S., Griffith B. P., Hardesty R. L., Bahnson H. T., Starzl T. E. Venous bypass in clinical liver transplantation. Ann Surg. 1984 Oct;200(4):524–534. doi: 10.1097/00000658-198410000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES